Promisingly, A2AR inhibition by the small molecule CPI-444 and CXCR2 inhibition by the small molecule SB225002 abrogated tumor growth and NET area in murine xenografts; CPI-444 treatment suppressed CXCL5 expression [102]. The gene discussed is CXCR2; the disease is neoplasm.